1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. PROTAGONIST THERAPEUTICS INC
Protagonist Therapeutics Inc XNAS: PTGX

Protagonist Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Await Turnaround
about

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline p...

Read More
58.59 0.21 (0.36%)
75.89% Gain from 52W Low
597.5K
XNAS Volume

XNAS 16 Sep, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The latest board meeting for Protagonist Therapeutics Inc took place on 16 Sep 2025, for the purpose of BofA 11th Annual World Medical Innovation Forum See details
Durability score
Low Financial Strength
27.8 / 100
Valuation Score
Mid Valuation
30.3 / 100
Momentum Score
Technically Neutral
59.0 / 100
Await Turnaround These stocks are of poor quality, but mid-range financials and valuations. Their performance may improve based on financials, however our advise would be to be careful before buying these stocks. View Similar Embed DVM
Analyst Price Target
70
1Yr Price target upside is 19%
12 analysts

20

S

15

W

5

O

1

T

SWOT Analysis

Protagonist Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..